1 enrolling by invitation, 1 withdrawn. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
Follow Medication Toxicity: new trials by email Literature Review of Medication Toxicity trials Research Report on Medication Toxicity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety & Efficacy of Baclofen for Alcohol Withdrawal in Chronic Liver Disease With Active Alcohol Consumption Baclofen - Alcoholic Cirrhosis, Alcohol Abstinence | Enrolling by invitation | Corporacion Parc Tauli | 120 | 2022-12-22 | 2025-02-21 | |
| Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy Volunteers AMXT 1501, Placebo Oral Tablet - Neoplasms, Medication Toxicity | Phase 1 | Withdrawn | Aminex Therapeutics, Inc. | 2018-06-12 | 2018-06-14 |
Drug-Related Side Effects and Adverse Reactions (2) · Alcohol Abstinence (1) · Liver Cirrhosis, Alcoholic (1) · Medication Adherence (1) · Neoplasms (1)
Chemically-Induced Disorders (2) · Alcohol-Induced Disorders (1) · Alcohol-Related Disorders (1) · Behavior (1) · Digestive System Diseases (1) · Drinking Behavior (1) · Fibrosis (1) · Health Behavior (1) · Liver Cirrhosis (1) · Liver Diseases (1) · Liver Diseases, Alcoholic (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Patient Acceptance of Health Care (1) · Patient Compliance (1)
Baclofen (1)
Aminex Therapeutics, Inc. (1) · Corporacion Parc Tauli (1)
Spain (1) · United States (1)